These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

887 related articles for article (PubMed ID: 22767401)

  • 1. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.
    Liu R; Liu Z; Zhang C; Zhang B
    J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.
    Li J; Tan G; Cheng B; Liu D; Pan W
    Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of Nanotechnological Carriers for Ocular Delivery of Mangiferin: Preformulation Study.
    Santonocito D; Vivero-Lopez M; Lauro MR; Torrisi C; Castelli F; Sarpietro MG; Puglia C
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanostructured lipid carriers-based thermosensitive eye drops for enhanced, sustained delivery of dexamethasone.
    Mo Z; Ban J; Zhang Y; Du Y; Wen Y; Huang X; Xie Q; Shen L; Zhang S; Deng H; Hou D; Chen Y; Lu Z
    Nanomedicine (Lond); 2018 Jun; 13(11):1239-1253. PubMed ID: 29949466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
    Nagaich U; Gulati N
    Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel surface-modified nanostructured lipid carriers with partially deacetylated water-soluble chitosan for efficient ocular delivery.
    Tian B; Luo Q; Song S; Liu D; Pan H; Zhang W; He L; Ma S; Yang X; Pan W
    J Pharm Sci; 2012 Mar; 101(3):1040-9. PubMed ID: 22102480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.
    Cirri M; Bragagni M; Mennini N; Mura P
    Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability.
    Patel N; Nakrani H; Raval M; Sheth N
    Drug Deliv; 2016 Nov; 23(9):3712-3723. PubMed ID: 27689408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermosensitive in situ nanogel as ophthalmic delivery system of curcumin: development, characterization, in vitro permeation and in vivo pharmacokinetic studies.
    Liu R; Sun L; Fang S; Wang S; Chen J; Xiao X; Liu C
    Pharm Dev Technol; 2016 Aug; 21(5):576-82. PubMed ID: 26024239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
    Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W
    Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues.
    Balguri SP; Adelli GR; Majumdar S
    Eur J Pharm Biopharm; 2016 Dec; 109():224-235. PubMed ID: 27793755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Thermoresponsive Eyedrop Formulation Containing Ibuprofen Loaded-Nanostructured Lipid Carriers (NLC): Development, Characterization and Biocompatibility Studies.
    Almeida H; Lobão P; Frigerio C; Fonseca J; Silva R; Palmeira-de-Oliveira A; Lobo JM; Amaral MH
    Curr Drug Deliv; 2016; 13(6):953-70. PubMed ID: 26502890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin.
    Liu D; Li J; Pan H; He F; Liu Z; Wu Q; Bai C; Yu S; Yang X
    Sci Rep; 2016 Jun; 6():28796. PubMed ID: 27350323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels.
    He W; Guo X; Feng M; Mao N
    Int J Pharm; 2013 Dec; 458(2):305-14. PubMed ID: 24409520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
    Khurana S; Jain NK; Bedi PM
    Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability.
    Gan L; Han S; Shen J; Zhu J; Zhu C; Zhang X; Gan Y
    Int J Pharm; 2010 Aug; 396(1-2):179-87. PubMed ID: 20558263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery.
    Lakhani P; Patil A; Wu KW; Sweeney C; Tripathi S; Avula B; Taskar P; Khan S; Majumdar S
    Int J Pharm; 2019 Dec; 572():118771. PubMed ID: 31669555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: Mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability.
    Zeng W; Li Q; Wan T; Liu C; Pan W; Wu Z; Zhang G; Pan J; Qin M; Lin Y; Wu C; Xu Y
    Colloids Surf B Biointerfaces; 2016 May; 141():28-35. PubMed ID: 26820107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.